CWP
WST icon

Curated Wealth Partners’s West Pharmaceutical WST Stock Holding History

Curated Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
+8,544
New +$2.61M 0.05% 362

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Curated Wealth Partners's WST Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 8,544 shares worth $368K. The stake represents 0.05% of the portfolio and ranks #362 among its holdings.

229 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Curated Wealth Partners held 8,544 shares of West Pharmaceutical worth $368K as of Q2 2026.
  • West Pharmaceutical was a new Curated Wealth Partners position in Q2 2026.
  • West Pharmaceutical made up 0.05% of Curated Wealth Partners's portfolio in Q2 2026, its #362 holding.
  • 229 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.